Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tetralogic Pharma (TLOG)
OTHER OTC:TLOG
Holding TLOG?
Track your performance easily
TLOG Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume107.58K
Average Volume (3M)4.62K
Market Cap
$24.00
Enterprise ValueN/A
Total Cash (Recent Filing)$15.53M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta16.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding24,465,000
10 Day Avg. Volume0
30 Day Avg. Volume4,618
Standard Deviation0.73
R-Squared0.07
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
TLOG FAQ
What was Tetralogic Pharma’s price range in the past 12 months?
Currently, no data Available
What is Tetralogic Pharma’s market cap?
Tetralogic Pharma’s market cap is $24.00.
When is Tetralogic Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tetralogic Pharma’s earnings last quarter?
Currently, no data Available
Is Tetralogic Pharma overvalued?
According to Wall Street analysts Tetralogic Pharma’s price is currently Overvalued.
Does Tetralogic Pharma pay dividends?
Tetralogic Pharma does not currently pay dividends.
What is Tetralogic Pharma’s EPS estimate?
Tetralogic Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tetralogic Pharma have?
Tetralogic Pharma has 24,465,000 shares outstanding.
What happened to Tetralogic Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tetralogic Pharma?
Currently, no hedge funds are holding shares in TLOG
---
Company Description
Tetralogic Pharma
TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. The firm focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE. The company was founded by Yigong Shi, John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.
---
Agenus
―
Fate Therapeutics
―
Karyopharm Therapeutics
―
Viking Therapeutics
―
Adaptimmune Therapeutics
―
---